Device Authority targets a core security gap in healthcare

Tern plc

Legacy medical devices are not disappearing from healthcare networks. Many hospitals still depend on older equipment that remains clinically useful, expensive to replace and difficult to take offline. That reality creates a clear security challenge: connected medical devices need to be protected even when they were not designed for today’s cybersecurity demands.

Device Authority argues that healthcare organisations need an identity-first security strategy to manage this risk. It is not enough to know that a device is connected to a network. Healthcare providers need to know what the device is, whether it can be trusted, whether its credentials are valid and whether it should be allowed to communicate with other systems.

Many legacy medical devices were built before modern security standards became common. Some may lack strong authentication. Others may rely on outdated software, limited update options or weak certificate management. In a hospital setting, these weaknesses can be difficult to fix quickly because the devices may support critical services and cannot always be replaced or patched without affecting clinical operations.

An identity-first approach puts the device itself at the centre of the security model. Each device needs a trusted identity that can be issued, managed, renewed and revoked across its lifecycle. This makes it easier to control access, reduce exposure and support compliance without depending only on network-based defences. It also gives healthcare organisations a more practical way to manage risk across mixed estates of new and old devices.

For Device Authority, the message is commercially relevant. Healthcare is a sector where connected-device security is not optional, but replacement cycles are long and operational disruption carries real consequences.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Device Authority strengthens position in machine identity and Zero Trust Security

Device Authority’s inclusion in two 2026 Gartner Hype Cycle reports reinforces its positioning in machine identity, IoT authentication and Zero Trust security.

Talking Medicines highlights strategic value of patient journey intelligence

Patient journey intelligence can help healthcare organisations identify care barriers and design more responsive pathways around real patient experiences.

Evidence-based care pathways support more consistent healthcare delivery

Evidence-based care pathways can improve diagnosis, treatment consistency and the integration of new therapies into routine care.

Tern increases Talking Medicines funding and raises shareholder distribution commitment

Tern has invested in additional Talking Medicines convertible loan notes and increased its minimum shareholder distribution commitment to 70% on qualifying exits.

Evidence-based care pathways create clearer routes to adoption

Evidence-based care pathways can reduce delays, improve treatment consistency and support the adoption of new therapies.

Talking Medicines highlights the data opportunity emerging around GLP-1 care

Talking Medicines examines how the expanding GLP-1 market is increasing the importance of clear distinctions between approved therapies, compounded medicines and nutritional support.

Search